Back
Cava Group Vs. Ascendis Pharma AS Industry Stock Comparison
Buy
84
CAVA
Cava Group
Last Price:
124.29
Seasonality Move:
13.04%
Sell
41
ASND
Ascendis Pharma AS
Last Price:
149.16
Seasonality Move:
6.54%
Buy
84
Cava Group (CAVA)
is a Buy
Is Cava Group a Buy, Sell or Hold?
- The current Cava Group [CAVA] share price is $124.30. The Score for CAVA is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.
- CAVA is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $148.89. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CAVA Stock Price Chart
What is Cava Group's stock price today?
-
The Cava Group share price today is $124.30
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CAVA is experiencing slight selling pressure.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $148.89
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing slight buying pressure.
CAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.04 | Buy |
| Relative Strength Index (14 RSI): | 67.44 | Buy |
| Chaikin Money Flow: | -77164 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (103.88 - 123.46) | Buy |
| Bollinger Bands (100): | (76.48 - 106.68) | Buy |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 68.26 | Buy |
| Chaikin Money Flow: | 280060 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (121.33 - 143.31) | Buy |
| Bollinger Bands (100): | (125.42 - 139.7) | Buy |
CAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 122.33 | Buy |
| 20-day SMA: | 117.58 | Buy |
| 50-day SMA: | 98.58 | Buy |
| 200-day SMA: | 72.07 | Buy |
| 8-day EMA: | 121.76 | Buy |
| 20-day EMA: | 115.82 | Buy |
| 50-day EMA: | 104.24 | Buy |
| 200-day EMA: | 77.45 | Buy |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 126.6 | Buy |
| 20-day SMA: | 130.69 | Buy |
| 50-day SMA: | 132.91 | Buy |
| 200-day SMA: | 135.36 | Buy |
| 8-day EMA: | 133.29 | Buy |
| 20-day EMA: | 130.71 | Buy |
| 50-day EMA: | 131.94 | Buy |
| 200-day EMA: | 129.45 | Buy |
Cava Group Earnings Growth & CAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.03 per share, an increase this year of $0.31 per share, and an increase next year of $0.09 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.76 per share, an increase next quarter of $1.52 per share, an increase this year of $1.66 per share, and an increase next year of $4.42 per share.
Cava Group Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||